{"id":26268,"date":"2020-10-20T06:03:33","date_gmt":"2020-10-20T06:03:33","guid":{"rendered":"https:\/\/bengalnewstimes.com\/?p=26268"},"modified":"2020-10-20T06:03:33","modified_gmt":"2020-10-20T06:03:33","slug":"remdesivir-doesnt-reduce-covid-19-patients-risk-of-death-study","status":"publish","type":"post","link":"https:\/\/bengalnewstimes.com\/?p=26268","title":{"rendered":"Remdesivir Doesn&#8217;t Reduce COVID-19 Patients&#8217; Risk of Death: Study"},"content":{"rendered":"<p><\/p>\n<div>\n<p>MONDAY, Oct. 19, 2020 (HealthDay News) &#8212; The antiviral drug remdesivir doesn&#8217;t reduce <a href=\"https:\/\/www.medicinenet.com\/wuhan_coronavirus_2019-ncov\/article.htm\" onclick=\"wmdTrack('embd-lnk');\" rel=\"dt\">COVID-19<\/a> patients&#8217; risk of death, a new study says.<\/p>\n<p>The World Health Organization-sponsored study of the drug &#8212; the only antiviral authorized for treatment of <a href=\"https:\/\/www.medicinenet.com\/wuhan_coronavirus_outbreak_2019-ncov\/article.htm\" onclick=\"wmdTrack('embd-lnk');\" rel=\"slide\">COVID-19<\/a> in the United States &#8211;included more than 11,000 people in 30 countries, <i>The New York Times<\/i> reported.<\/p>\n<p>The findings were posted online on Thursday, but have not yet been peer-reviewed or published in a scientific journal.<\/p>\n<p>&#8220;This puts the issue to rest &#8212; there is certainly no mortality benefit,&#8221; Dr. Ilan Schwartz, an infectious-disease physician at the University of Alberta in Canada, told <i>The Times<\/i>.<\/p>\n<p>However, another infectious-disease expert expressed caution about the findings.<\/p>\n<p>A large trial like this that&#8217;s conducted in numerous countries with different health care systems can result in inconsistent treatment protocols whose effects can be difficult to analyze, Dr. Peter Chin-Hong, University of California, San Francisco, told <i>The Times<\/i>.<\/p>\n<p>&#8220;So much goes into care,&#8221; he said. &#8220;The drug is only part of it.&#8221;<\/p>\n<p>Remdesivir&#8217;s maker, Gilead, challenged the study&#8217;s findings. The company said more rigorous studies had found a benefit, <i>The Times<\/i> reported.<\/p>\n<p>Remdesivir was granted emergency authorization by the U.S. Food and Drug Administration in May after a U.S. National Institutes of Health study concluded that the drug modestly reduced the time to recovery in severely ill <a href=\"https:\/\/www.medicinenet.com\/wuhan_coronavirus_2019-ncov_symptoms_and_signs\/symptoms.htm\" onclick=\"wmdTrack('embd-lnk');\" rel=\"sym\">COVID-19<\/a> patients.<\/p>\n<p>But that study didn&#8217;t find that remdesivir prevented deaths in <a href=\"https:\/\/www.medicinenet.com\/wuhan_coronavirus_2019-ncov\/article.htm\" rel=\"dt\" onclick=\"wmdTrack('embd-lnk');\">COVID-19<\/a> patients. A final analysis published Oct. 8 in the <i>New England Journal of Medicine<\/i> suggested &#8220;a trend toward reduced mortality&#8221; in certain <a href=\"https:\/\/www.medicinenet.com\/wuhan_coronavirus_outbreak_2019-ncov\/article.htm\" rel=\"slide\" onclick=\"wmdTrack('embd-lnk');\">COVID-19<\/a> patients who received remdesivir, according to Gilead.<\/p>\n<p class=\"credits\"><img decoding=\"async\" alt=\"MedicalNews\" border=\"0\" src=\"https:\/\/images.medicinenet.com\/images\/HealthDay\/healthday.png\" style=\"border: none;\"\/><br \/>Copyright \u00a9 2019 HealthDay. All rights reserved.<\/p>\n<p>                            <!--CONTINUEREADING--><br \/>\n<a class=\"mediaPrmo ss\" href=\"https:\/\/www.medicinenet.com\/weight_gain_shockers_pictures_slideshow\/article.htm\" onclick=\"wmdTrack('ssprmo-arttop');\" target=\"_blank\" rel=\"noopener noreferrer\">&#13;<br \/>\n    <img decoding=\"async\" src=\"https:\/\/images.medicinenet.com\/\/images\/slideshow\/weight_gain_shockers_s1_muffin_top.jpg\"\/><span class=\"skew\"\/>&#13;<br \/>\n    <span class=\"icon-slideshow\"\/>&#13;<\/p>\n<h4 class=\"label\">SLIDESHOW<\/h4>\n<p>&#13;<br \/>\n    <span class=\"caption\">Surprising Reasons for Weight Gain <\/span>&#13;<br \/>\n    <span class=\"btn\">See Slideshow<\/span>&#13;<br \/>\n<\/a><\/p><\/div>\n<p><script>\n!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod?\nn.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n;\nn.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;\nt.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,\ndocument,'script','\/\/connect.facebook.net\/en_US\/fbevents.js');<\/p>\n<p>fbq('init', '428750600651790');\nfbq('track', \"PageView\");<\/script><br \/>\n<br \/><a href=\\\"http:\/\/www.medicinenet.com\/script\/main\/art.asp?articlekey=247914\\\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MONDAY, Oct. 19, 2020 (HealthDay News) &#8212; The antiviral drug remdesivir doesn&#8217;t reduce COVID-19 patients&#8217; risk of death, a new study says. The World Health Organization-sponsored study of the drug &#8212; the only antiviral authorized for treatment of COVID-19 in the United States &#8211;included more than 11,000 people in 30 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":24708,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"spay_email":"","footnotes":""},"categories":[11],"tags":[],"class_list":["post-26268","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-life-style"],"jetpack_featured_media_url":"https:\/\/bengalnewstimes.com\/wp-content\/uploads\/2020\/09\/1601354401_fb-mnet-default.jpg","_links":{"self":[{"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=\/wp\/v2\/posts\/26268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=26268"}],"version-history":[{"count":0,"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=\/wp\/v2\/posts\/26268\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=\/wp\/v2\/media\/24708"}],"wp:attachment":[{"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=26268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=26268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=26268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}